- Zacks•last month
Hologic, Inc. (HOLX) recently inked a deal to divest its stake in the blood screening business.
- Investor's Business Daily•last month
Hologic sold its declining blood screening venture to partner Grifols. The $1.8 billion price was "lofty" according to a Canaccord analyst.
- TheStreet.com•last month
Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.
GRFS : Summary for Grifols, S.A. - American Deposi - Yahoo Finance
Grifols, S.A. (GRFS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||11.75 x 200|
|Day's Range||16.81 - 16.98|
|52 Week Range||14.07 - 17.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||41.32|
|Dividend & Yield||0.39 (2.30%)|
|1y Target Est||N/A|